A nurse is assessing a client who is recovering from subarachnoid hemorrhage following a fall. Which of the following medications should the nurse understand is a potential reason for the fall? (Select All that Apply.)

A. "Medications for Alzheimer's disease will help to increase my energy levels": This statement is not accurate. Medications for Alzheimer's disease, such as cholinesterase inhibitors (e.g., donepezil, rivastigmine) and memantine, are not intended to increase energy levels. Their primary goal is to improve cognitive function and help manage symptoms associated with Alzheimer's disease, but they do not directly affect energy levels.

B. "Medications for Alzheimer's disease will help slow the progression of my disease": This statement is correct. Medications used to treat Alzheimer's disease, such as cholinesterase inhibitors and memantine, are aimed at slowing the progression of cognitive decline and managing symptoms associated with the disease. While these medications cannot cure Alzheimer's disease, they can help improve cognitive function and quality of life for some individuals.

C. "Medications for Alzheimer's disease will help me remember what I forgot": This statement oversimplifies the effects of Alzheimer's medications. While these medications may help improve memory and cognition to some extent, they are not capable of restoring lost memories or reversing the effects of significant memory impairment caused by Alzheimer's disease.

D. "Medications for Alzheimer's disease will cure the disease": This statement is incorrect. Currently, there is no cure for Alzheimer's disease. Medications used to treat Alzheimer's, such as cholinesterase inhibitors and memantine, can help manage symptoms and slow disease progression, but they do not cure the underlying condition.

A. Increased number of individuals utilizing technology in their homes: While technology use may impact various aspects of cognitive function and mental health, there is insufficient evidence to suggest a direct correlation between technology use and the growing numbers of clients diagnosed with dementia.

B. Increased number of the population living longer: One of the primary risk factors for dementia is advancing age. As the population ages and life expectancy increases, there is a higher prevalence of dementia due to the age-related degenerative changes in the brain.

C. Increased number of Americans over the age of 65: Aging is the most significant risk factor for dementia. The aging population, particularly those over 65 years old, is experiencing a higher prevalence of dementia due to age-related changes in the brain.

D. Increased number of the population traveling abroad: There is no direct association between traveling abroad and the growing numbers of clients diagnosed with dementia in the United States. While certain environmental factors or exposures may influence dementia risk, travel patterns are not considered a significant contributing factor to the overall prevalence of dementia.

E. Increased number of Americans attending college: There is no evidence to suggest a direct link between attending college and the prevalence of dementia. Educational attainment may have a protective effect against dementia, but it is not a factor driving the growing numbers of diagnoses in the United States.